Inferra AIResearch Tools

Inferra AI / Company / FMS

Fresenius Medical Care Ag

FMS · Health Care

Last earnings Aug 4, 2026

AI analysis

Q2 2025 · reported Aug 5, 2025

Based on: Earnings release — transcript not held

No extracted figures held

The event-summary record for this company carries no extracted figures, so the brief and charts cannot be drawn yet. The summary below and the held documents are the record for this event.

Guidance · company-stated

No guidance located in the held release

Next earningsNo verified date on fileNo date is estimated or imported
General educational research only — not investment advice.Every figure is as stated in the held documents; values marked “computed from stated figures” are arithmetic on those stated figures. Guidance shown is the company’s own stated guidance. No price targets, no recommendations, no consensus estimates.

Event summary

20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025

Based on: Earnings release — transcript not held

Guidance & outlook

No guidance located in the held release

Strategy & priorities

The Value-Based Care operating segment is primarily focused on value-based kidney care, including contracting and performance management, clinical care models supported by a national network of nephrologists and tech-enabled platforms that leverage proprietary informatics and patient engagement tools.

SEC original ↗Fresenius Medical Care Ag — Earnings release (6-K report)6-KAug 5, 2025

On June 17, 2025, we launched our new strategy, FME Reignite, announcing our increased profitability aspirations for 2030 and a new capital allocation framework to enhance value creation.

SEC original ↗Fresenius Medical Care Ag — Earnings release (6-K report)6-KAug 5, 2025

Included within the announcement was the expansion of the transformation of our operating structure and steps to achieve cost savings (FME25 Program) by two years.

SEC original ↗Fresenius Medical Care Ag — Earnings release (6-K report)6-KAug 5, 2025

Focused on extending President Trump s 2017 tax cuts and other domestic policy priorities, the OBBBA includes provisions that limit coverage in Medicaid, Medicare and the ACA exchanges.

SEC original ↗Fresenius Medical Care Ag — Earnings release (6-K report)6-KAug 5, 2025

Risks & headwinds

Although we believe that the assumptions and expectations reflected in such forward-looking statements are reasonable, forward-looking statements are inherently subject to risks and uncertainties, many of which cannot be predicted with accuracy and some of which might not be anticipated.

SEC original ↗Fresenius Medical Care Ag — Earnings release (6-K report)6-KAug 5, 2025

By their nature, such forward-looking statements involve risks, uncertainties, assumptions and other factors which could cause actual results, including our financial condition and profitability, to differ materially, positively or negatively, relative to the results expressly or implicitly described in or suggested by these statements.

SEC original ↗Fresenius Medical Care Ag — Earnings release (6-K report)6-KAug 5, 2025

These risks, uncertainties, assumptions, and other factors, including associated costs, could cause actual results to differ from our projected results and include, among others, the following: changes in governmental and private payor reimbursement for our complete products and services portfolio, including the United States (U.

SEC original ↗Fresenius Medical Care Ag — Earnings release (6-K report)6-KAug 5, 2025

Securities and Exchange Commission s (SEC) climate disclosure rules (which have been stayed and are not being defended by the SEC in litigation contesting their validity, in which the SEC has recently requested a ruling on their validity from the Eighth Circuit Court of Appeals) and (in each case) other similar state laws, as well as the Food, Drug and Cosmetic Act and, outside the U.

SEC original ↗Fresenius Medical Care Ag — Earnings release (6-K report)6-KAug 5, 2025

, the interpretation of these statutes and the validity of existing interpretations by the agencies that administer such statutes may be subject to increased uncertainty as a result of the U.

SEC original ↗Fresenius Medical Care Ag — Earnings release (6-K report)6-KAug 5, 2025

While the effects of the Loper Bright decision will become apparent over the succeeding months and years, it is possible that the decision could result in additional litigation challenging regulations, guidance, and decisions issued by agencies such as the U.

SEC original ↗Fresenius Medical Care Ag — Earnings release (6-K report)6-KAug 5, 2025

Documents

Earnings deck slides

0 decks with slide view

Fresenius Medical Care Ag — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.

Fresenius Medical Care Ag — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.

Competitors

Competitors & peers

Same GICS sector — classification peers, not declared competitors

Gilead Sciences (GILD) Health CareGenmab (GMAB) Health CareAlcon (ALC) Health CareArgenx (ARGX) Health CareSanofi (SNY) Health CareMerck & Co. (MRK) Health CareXencor Inc (XNCR) Health CareIllumina, Inc. (ILMN) Health Care

Filings

35 documents

Earnings releases

8 documents

Presentations

2 documents

Transcripts

0 documents

No transcripts for Fresenius Medical Care Ag are held in this edition of the library.

Mentioned by

7 companies

Other tracked companies whose held documents mention Fresenius Medical Care Ag by name or ticker. A mention is counted once per document, from the document text the library holds.

See also the earnings calendar for every tracked company’s next earnings date.